Roberta Alfieri
Università degli Studi di Parma
H-index: 45
Europe-Italy
Top articles of Roberta Alfieri
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies | British Journal of Cancer | A Leonetti M Verzè R Minari F Perrone L Gnetti | 2024/1/31 |
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) | Lung Cancer | A Cavazzoni G Digiacomo F Volta R Alfieri E Giovannetti | 2024/1/1 |
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment | Cancer Research Communications | Giorgia Maroni Indira Krishnan Roberta Alfieri Valerie A Maymi Nicole Pandell | 2024/3/26 |
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer … | Biochemical Pharmacology | Kamal Eltayeb Roberta Alfieri Claudia Fumarola Mara Bonelli Maricla Galetti | 2024/3/24 |
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models | Scientific Reports | Silvia La Monica Federica Vacondio Kamal Eltayeb Alessio Lodola Francesco Volta | 2024/3/18 |
TERRA ONTseq: a long read-based sequencing pipeline to study the human telomeric transcriptome | bioRxiv | Joana Rodrigues Roberta Alfieri Silvia Bione Claus Azzalin | 2023 |
Micro-fragmented fat inhibits the progression of human mesothelioma xenografts in mice | Current Cancer Drug Targets | Silvia La Monica Valentina Coccé Mara Bonelli Giulio Alessandri Roberta Alfieri | 2023/9/1 |
CDK4/6 INHIBITORS AS A NEW THERAPEUTIC APPROACH IN MESOTHELIOMA MODELS | S La Monica M Galetti R Alfieri A Cavazzoni C Fumarola | 2023 | |
Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma | Biochemical Pharmacology | Valentina Coccè Mara Bonelli Silvia La Monica Roberta Alfieri Luisa Doneda | 2023/8/1 |
PD-L1 OVEREXPRESSION INDUCES ANGIOGENIC CYTOKINE SECRETION AND ENDOTHELIAL CELL MIGRATION VIA STAT SIGNALLING. | G Digiacomo A Cavazzoni F Volta R Alfieri PG Petronini | 2023 | |
Alternative splicing changes promoted by NOVA2 upregulation in endothelial cells and relevance for gastric cancer | International journal of molecular sciences | Anna Di Matteo Elisa Belloni Davide Pradella Anna Maria Chiaravalli Giacomo Maria Pini | 2023/4/30 |
Unraveling Pathophysiology and Hematopoiesis of Vexas Syndrome By Multi-Omics Analyses and Targeted Gene Editing | Blood | Raffaella Molteni Martina Fiumara Corrado Campochiaro Alessandro Tomelleri Elisa Diral | 2023/12/1 |
State of the art and perspectives in pediatric hepatocellular carcinoma | Graziana Digiacomo Roberta Pia Serra Elena Turrini Alessandra Tiri Andrea Cavazzoni | 2023/1/1 | |
Sex specific regulation of TSPY-Like 2 in the DNA damage response of cancer cells | Cell Death & Disease | Miriana Cardano Martina Magni Roberta Alfieri Siu Yuen Chan Simone Sabbioneda | 2023/3/15 |
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators | Targeted Oncology | Francesco Volta Silvia La Monica Alessandro Leonetti Letizia Gnetti Mara Bonelli | 2023/11 |
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC | International Journal of Molecular Sciences | Maria Pia Adorni Maricla Galetti Silvia La Monica Matteo Incerti Alessandro Ruffoni | 2023/1/4 |
A new potential therapeutic approach on mesothelioma with mesenchymal stromal cells loaded with Paclitaxel (PacliMES) | Eleonora Martegani Valentina Coccè Mara Bonelli Silvia La Monica Roberta Alfieri | 2023/10/19 | |
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells | Frontiers in Oncology | Graziana Digiacomo Claudia Fumarola Silvia La Monica Mara Bonelli Andrea Cavazzoni | 2022/7/22 |
YES1 and MYC amplifications as synergistic resistance mechanisms to different generation ALK tyrosine kinase inhibitors in advanced NSCLC: Brief report of clinical and … | JTO Clinical and Research Reports | Roberta Minari Samuel Valentini Denise Madeddu Andrea Cavazzoni Silvia La Monica | 2022/2/1 |
Reprogramming of lipid metabolism in lung cancer: An overview with focus on EGFR-Mutated non-small cell lung cancer | Kamal Eltayeb Silvia La Monica Marcello Tiseo Roberta Alfieri Claudia Fumarola | 2022/1/25 |
